Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, V.
Right arrow Articles by Collins, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, V.
Right arrow Articles by Collins, S. J.
Related Collections
Right arrow Prion
NEUROLOGY 2005;65:113-118
© 2005 American Academy of Neurology

Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles

V. Lewis, BSc, A. F. Hill, PhD, G. M. Klug, BSc, A. Boyd, Post Grad Dip, C. L. Masters, MD and S. J. Collins, MD

From the Australian National Creutzfeldt–Jakob Disease Registry, Department of Pathology (Drs. Masters and Collins, V. Lewis, G.M. Klug, and A. Boyd), and Department of Biochemistry and Molecular Biology (Dr. Hill), University of Melbourne, and Mental Health Research Institute of Victoria (Drs. Hill, Masters, and Collins, V. Lewis, G.M. Klug, and A. Boyd), Parkville, Victoria, Australia.

Address correspondence and reprint requests to Dr Collins, Australian National CJD Registry, University of Melbourne, Melbourne, Victoria, Australia, 3010; e-mail: stevenjc{at}unimelb.edu.au

Objective: To define the protease-resistant prion protein (PrPres) types and associated clinical profiles in Australian patients with sporadic Creutzfeldt–Jakob disease (CJD) to allow comparison with those reported from other continents and concomitantly reaffirm absence of variant CJD (vCJD).

Methods: Reassessment of available clinical and neuropathologic data on patients referred to the Australian National Creutzfeldt–Jakob Disease Registry (ANCJDR) who died between January 1, 1992, and June 30, 2003, was conducted. Molecular classification of PrPres was determined by immunoblot analysis of available frozen brain tissue. Brain homogenate pH and codon 129 genotype on the prion protein gene (PRNP) were established.

Results: PrPres patterns in 35 of 37 patients with sporadic CJD conformed to one of three common reported types. Of a range of clinical features assessed, illness duration was the only clinical feature significantly associated with PrPres type. Two patients displayed coexistence of more than one PrP type, with one displaying a novel pattern of three PrPres types in a single brain region. The absence of vCJD was reconfirmed, supported by the lack of the typical PrPres glycoform pattern.

Conclusions: Given Australia’s geographic isolation and environmental uniqueness, the general congruity of these results with those reported from other continents suggests that endogenous factors predominantly determine sporadic Creutzfeldt–Jakob disease (CJD) phenotypic subtypes or "strains." These results support a clinicopathologic classification system whereby both PrPres type and codon 129 genotype are utilized to most accurately depict phenotypic subtypes or strains of sporadic CJD.


Funded in part by a National Health and Medical Research Council (NHMRC) program grant (208978). The Australian National Creutzfeldt–Jakob disease Registry is funded by the Commonwealth Department of Health and Aging. Dr. Hill receives an NHMRC RD Wright Fellowship.

Received December 30, 2004. Accepted in final form March 25, 2005.




This article has been cited by other articles:


Home page
BrainHome page
I. Cali, R. Castellani, J. Yuan, A. Al-Shekhlee, M. L. Cohen, X. Xiao, F. J. Moleres, P. Parchi, W.-Q. Zou, and P. Gambetti
Classification of sporadic Creutzfeldt-Jakob disease revisited.
Brain, September 1, 2006; 129(Pt 9): 2266 - 2277.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge
Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations
Brain, March 1, 2006; 129(3): 676 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.